Esophageal Cancer Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 61 pages | ID: E3DAAEEA59B7EN
Market Monitor Global

Abstracts

Esophageal cancer is cancer arising from the esophagus—the food pipe that runs between the throat and the stomach.Symptoms often include difficulty in swallowing and weight loss.Other symptoms may include pain when swallowing, a hoarse voice, enlarged lymph nodes ('glands') around the collarbone, a dry cough, and possibly coughing up or vomiting blood.

This report contains market size and forecasts of Esophageal Cancer Drugs in Global, including the following market information:

Global Esophageal Cancer Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Esophageal Cancer Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Fluorouracil Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Esophageal Cancer Drugs include Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Merck & Co., Inc. and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Esophageal Cancer Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Esophageal Cancer Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Esophageal Cancer Drugs Market Segment Percentages, by Type, 2021 (%)

• Fluorouracil
• Cisplatin
• Docetaxel
• Carboplatin
• Others

Global Esophageal Cancer Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Esophageal Cancer Drugs Market Segment Percentages, by Application, 2021 (%)

• Targeted Therapy
• Chemotherapy

Global Esophageal Cancer Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Esophageal Cancer Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Esophageal Cancer Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Esophageal Cancer Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• Merck & Co., Inc.
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Esophageal Cancer Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Esophageal Cancer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ESOPHAGEAL CANCER DRUGS OVERALL MARKET SIZE

2.1 Global Esophageal Cancer Drugs Market Size: 2021 VS 2028
2.2 Global Esophageal Cancer Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Esophageal Cancer Drugs Players in Global Market
3.2 Top Global Esophageal Cancer Drugs Companies Ranked by Revenue
3.3 Global Esophageal Cancer Drugs Revenue by Companies
3.4 Top 3 and Top 5 Esophageal Cancer Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Esophageal Cancer Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Esophageal Cancer Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Esophageal Cancer Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Esophageal Cancer Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Esophageal Cancer Drugs Market Size Markets, 2021 & 2028
  4.1.2 Fluorouracil
  4.1.3 Cisplatin
  4.1.4 Docetaxel
  4.1.5 Carboplatin
  4.1.6 Others
4.2 By Type - Global Esophageal Cancer Drugs Revenue & Forecasts
  4.2.1 By Type - Global Esophageal Cancer Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Esophageal Cancer Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Esophageal Cancer Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Esophageal Cancer Drugs Market Size, 2021 & 2028
  5.1.2 Targeted Therapy
  5.1.3 Chemotherapy
5.2 By Application - Global Esophageal Cancer Drugs Revenue & Forecasts
  5.2.1 By Application - Global Esophageal Cancer Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Esophageal Cancer Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Esophageal Cancer Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Esophageal Cancer Drugs Market Size, 2021 & 2028
6.2 By Region - Global Esophageal Cancer Drugs Revenue & Forecasts
  6.2.1 By Region - Global Esophageal Cancer Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Esophageal Cancer Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Esophageal Cancer Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Esophageal Cancer Drugs Revenue, 2017-2028
  6.3.2 US Esophageal Cancer Drugs Market Size, 2017-2028
  6.3.3 Canada Esophageal Cancer Drugs Market Size, 2017-2028
  6.3.4 Mexico Esophageal Cancer Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Esophageal Cancer Drugs Revenue, 2017-2028
  6.4.2 Germany Esophageal Cancer Drugs Market Size, 2017-2028
  6.4.3 France Esophageal Cancer Drugs Market Size, 2017-2028
  6.4.4 U.K. Esophageal Cancer Drugs Market Size, 2017-2028
  6.4.5 Italy Esophageal Cancer Drugs Market Size, 2017-2028
  6.4.6 Russia Esophageal Cancer Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Esophageal Cancer Drugs Market Size, 2017-2028
  6.4.8 Benelux Esophageal Cancer Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Esophageal Cancer Drugs Revenue, 2017-2028
  6.5.2 China Esophageal Cancer Drugs Market Size, 2017-2028
  6.5.3 Japan Esophageal Cancer Drugs Market Size, 2017-2028
  6.5.4 South Korea Esophageal Cancer Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Esophageal Cancer Drugs Market Size, 2017-2028
  6.5.6 India Esophageal Cancer Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Esophageal Cancer Drugs Revenue, 2017-2028
  6.6.2 Brazil Esophageal Cancer Drugs Market Size, 2017-2028
  6.6.3 Argentina Esophageal Cancer Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Esophageal Cancer Drugs Revenue, 2017-2028
  6.7.2 Turkey Esophageal Cancer Drugs Market Size, 2017-2028
  6.7.3 Israel Esophageal Cancer Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Esophageal Cancer Drugs Market Size, 2017-2028
  6.7.5 UAE Esophageal Cancer Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bristol-Myers Squibb Company
  7.1.1 Bristol-Myers Squibb Company Corporate Summary
  7.1.2 Bristol-Myers Squibb Company Business Overview
  7.1.3 Bristol-Myers Squibb Company Esophageal Cancer Drugs Major Product Offerings
  7.1.4 Bristol-Myers Squibb Company Esophageal Cancer Drugs Revenue in Global Market (2017-2022)
  7.1.5 Bristol-Myers Squibb Company Key News
7.2 Eli Lilly and Company
  7.2.1 Eli Lilly and Company Corporate Summary
  7.2.2 Eli Lilly and Company Business Overview
  7.2.3 Eli Lilly and Company Esophageal Cancer Drugs Major Product Offerings
  7.2.4 Eli Lilly and Company Esophageal Cancer Drugs Revenue in Global Market (2017-2022)
  7.2.5 Eli Lilly and Company Key News
7.3 F. Hoffmann-La Roche Ltd
  7.3.1 F. Hoffmann-La Roche Ltd Corporate Summary
  7.3.2 F. Hoffmann-La Roche Ltd Business Overview
  7.3.3 F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Major Product Offerings
  7.3.4 F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Revenue in Global Market (2017-2022)
  7.3.5 F. Hoffmann-La Roche Ltd Key News
7.4 Merck & Co., Inc.
  7.4.1 Merck & Co., Inc. Corporate Summary
  7.4.2 Merck & Co., Inc. Business Overview
  7.4.3 Merck & Co., Inc. Esophageal Cancer Drugs Major Product Offerings
  7.4.4 Merck & Co., Inc. Esophageal Cancer Drugs Revenue in Global Market (2017-2022)
  7.4.5 Merck & Co., Inc. Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi Esophageal Cancer Drugs Major Product Offerings
  7.5.4 Sanofi Esophageal Cancer Drugs Revenue in Global Market (2017-2022)
  7.5.5 Sanofi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Esophageal Cancer Drugs Market Opportunities & Trends in Global Market
Table 2. Esophageal Cancer Drugs Market Drivers in Global Market
Table 3. Esophageal Cancer Drugs Market Restraints in Global Market
Table 4. Key Players of Esophageal Cancer Drugs in Global Market
Table 5. Top Esophageal Cancer Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Esophageal Cancer Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Esophageal Cancer Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Esophageal Cancer Drugs Product Type
Table 9. List of Global Tier 1 Esophageal Cancer Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Esophageal Cancer Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Esophageal Cancer Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Esophageal Cancer Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Esophageal Cancer Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Esophageal Cancer Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Esophageal Cancer Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Esophageal Cancer Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Esophageal Cancer Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Esophageal Cancer Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Esophageal Cancer Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Esophageal Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Esophageal Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Esophageal Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Esophageal Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Esophageal Cancer Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Bristol-Myers Squibb Company Corporate Summary
Table 31. Bristol-Myers Squibb Company Esophageal Cancer Drugs Product Offerings
Table 32. Bristol-Myers Squibb Company Esophageal Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Eli Lilly and Company Corporate Summary
Table 34. Eli Lilly and Company Esophageal Cancer Drugs Product Offerings
Table 35. Eli Lilly and Company Esophageal Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 36. F. Hoffmann-La Roche Ltd Corporate Summary
Table 37. F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Product Offerings
Table 38. F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Merck & Co., Inc. Corporate Summary
Table 40. Merck & Co., Inc. Esophageal Cancer Drugs Product Offerings
Table 41. Merck & Co., Inc. Esophageal Cancer Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Esophageal Cancer Drugs Product Offerings
Table 44. Sanofi Esophageal Cancer Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Esophageal Cancer Drugs Segment by Type in 2021
Figure 2. Esophageal Cancer Drugs Segment by Application in 2021
Figure 3. Global Esophageal Cancer Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Esophageal Cancer Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Esophageal Cancer Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Esophageal Cancer Drugs Revenue in 2021
Figure 8. By Type - Global Esophageal Cancer Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Esophageal Cancer Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Esophageal Cancer Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Esophageal Cancer Drugs Revenue Market Share, 2017-2028
Figure 12. US Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Esophageal Cancer Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Esophageal Cancer Drugs Revenue Market Share, 2017-2028
Figure 24. China Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Esophageal Cancer Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Esophageal Cancer Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Esophageal Cancer Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Bristol-Myers Squibb Company Esophageal Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eli Lilly and Company Esophageal Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck & Co., Inc. Esophageal Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Esophageal Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)